Global Bilastine Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Hospital
Drug Store
Segment by Application
Urticaria
Allergic Rhinitis
Allergic Rhinoconjunctivitis
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Aralez Pharmaceuticals
Takeda
Menarini
Taiho Yakuhin
Faes Farma
Berlin Chemie
GlaxoSmithKline
Pierre Fabre
Table of Content
1 Bilastine Market Overview
1.1 Product Overview and Scope of Bilastine
1.2 Bilastine Segment by Type
1.2.1 Global Bilastine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Hospital
1.2.3 Drug Store
1.3 Bilastine Segment by Application
1.3.1 Bilastine Sales Comparison by Application: (2021-2027)
1.3.2 Urticaria
1.3.3 Allergic Rhinitis
1.3.4 Allergic Rhinoconjunctivitis
1.4 Global Bilastine Market Size Estimates and Forecasts
1.4.1 Global Bilastine Revenue 2016-2027
1.4.2 Global Bilastine Sales 2016-2027
1.4.3 Bilastine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Bilastine Market Competition by Manufacturers
2.1 Global Bilastine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Bilastine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Bilastine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Bilastine Manufacturing Sites, Area Served, Product Type
2.5 Bilastine Market Competitive Situation and Trends
2.5.1 Bilastine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Bilastine Players Market Share by Revenue
2.5.3 Global Bilastine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bilastine Retrospective Market Scenario by Region
3.1 Global Bilastine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Bilastine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Bilastine Market Facts & Figures by Country
3.3.1 North America Bilastine Sales by Country
3.3.2 North America Bilastine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Bilastine Market Facts & Figures by Country
3.4.1 Europe Bilastine Sales by Country
3.4.2 Europe Bilastine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Bilastine Market Facts & Figures by Region
3.5.1 Asia Pacific Bilastine Sales by Region
3.5.2 Asia Pacific Bilastine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Bilastine Market Facts & Figures by Country
3.6.1 Latin America Bilastine Sales by Country
3.6.2 Latin America Bilastine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Bilastine Market Facts & Figures by Country
3.7.1 Middle East and Africa Bilastine Sales by Country
3.7.2 Middle East and Africa Bilastine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Bilastine Historic Market Analysis by Type
4.1 Global Bilastine Sales Market Share by Type (2016-2021)
4.2 Global Bilastine Revenue Market Share by Type (2016-2021)
4.3 Global Bilastine Price by Type (2016-2021)
5 Global Bilastine Historic Market Analysis by Application
5.1 Global Bilastine Sales Market Share by Application (2016-2021)
5.2 Global Bilastine Revenue Market Share by Application (2016-2021)
5.3 Global Bilastine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Aralez Pharmaceuticals
6.1.1 Aralez Pharmaceuticals Corporation Information
6.1.2 Aralez Pharmaceuticals Description and Business Overview
6.1.3 Aralez Pharmaceuticals Bilastine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Aralez Pharmaceuticals Product Portfolio
6.1.5 Aralez Pharmaceuticals Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Corporation Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Bilastine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Takeda Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Menarini
6.3.1 Menarini Corporation Information
6.3.2 Menarini Description and Business Overview
6.3.3 Menarini Bilastine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Menarini Product Portfolio
6.3.5 Menarini Recent Developments/Updates
6.4 Taiho Yakuhin
6.4.1 Taiho Yakuhin Corporation Information
6.4.2 Taiho Yakuhin Description and Business Overview
6.4.3 Taiho Yakuhin Bilastine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Taiho Yakuhin Product Portfolio
6.4.5 Taiho Yakuhin Recent Developments/Updates
6.5 Faes Farma
6.5.1 Faes Farma Corporation Information
6.5.2 Faes Farma Description and Business Overview
6.5.3 Faes Farma Bilastine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Faes Farma Product Portfolio
6.5.5 Faes Farma Recent Developments/Updates
6.6 Berlin Chemie
6.6.1 Berlin Chemie Corporation Information
6.6.2 Berlin Chemie Description and Business Overview
6.6.3 Berlin Chemie Bilastine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Berlin Chemie Product Portfolio
6.6.5 Berlin Chemie Recent Developments/Updates
6.7 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Bilastine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GlaxoSmithKline Product Portfolio
6.7.5 GlaxoSmithKline Recent Developments/Updates
6.8 Pierre Fabre
6.8.1 Pierre Fabre Corporation Information
6.8.2 Pierre Fabre Description and Business Overview
6.8.3 Pierre Fabre Bilastine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Pierre Fabre Product Portfolio
6.8.5 Pierre Fabre Recent Developments/Updates
7 Bilastine Manufacturing Cost Analysis
7.1 Bilastine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Bilastine
7.4 Bilastine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Bilastine Distributors List
8.3 Bilastine Customers
9 Bilastine Market Dynamics
9.1 Bilastine Industry Trends
9.2 Bilastine Growth Drivers
9.3 Bilastine Market Challenges
9.4 Bilastine Market Restraints
10 Global Market Forecast
10.1 Bilastine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Bilastine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Bilastine by Type (2022-2027)
10.2 Bilastine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Bilastine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Bilastine by Application (2022-2027)
10.3 Bilastine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Bilastine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Bilastine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer